What is it about?
Idiopathic polyneuropathy patients often suffer from chronic neuropathic pain. The supplement palmitoylethanolamide is easy to use and should be considered more often. Recommended dose: 3 times 400 mg capsules daily.
Featured Image
Why is it important?
Because many analgesics have dose-dependent side effects limiting its use in CIAP patients, and PEA has not!
Perspectives
Palmitoylethanolamide should become a first step analgesic in chronic pain and should be used more often as it also has opioid sparing effects in chronic pain!
jan keppel hesselink
Institute Neuropathic Pain
Read the Original
This page is a summary of: Chronic idiopathic axonal neuropathy and pain, treated with the endogenous lipid mediator palmitoylethanolamide: a case collection, International Medical Case Reports Journal, September 2013, Taylor & Francis,
DOI: 10.2147/imcrj.s51572.
You can read the full text:
Contributors
The following have contributed to this page
